Skip to NavigationSkip to content

News

NICE has recommended POTELIGEO (mogamulizumab), manufactured by Kyowa Kirin, as a treatment option for adults in England in Wales with the ultra-rare...
A new study published in Science Advances has shared that cancer drugs can be repurposed as therapies to be tested in clinical trials, for those at...
Results from a clinical study, published by Ad Scientiam in ‘Multiple Sclerosis and Related Disorders, secure the place of  MSCopilot...
Pfizer have requested that the FDA authorise booster shots of the COVID-19 vaccine in all Americans 18 and older, citing data from a 10,000-person...
COMPASS Pathways, a mental health care company dedicated to the acceleration of patient access to evidence-based innovation in mental health, have...
Specialty biopharma company, Pleco Therapeutics, have announced the beginning of a strategic collaboration with Hyloris Pharmaceuticals, to develop...
The UK government has stated that Covaxin is to be added to its list of approved COVID-19 vaccines for international travelers from 22 November.
A new technique to turn therapeutic genes on in specifically targeted cells has been developed, a potential game-changer in the future of gene...
Regeneron Pharmaceuticals have said that a single dose of its antibody COVID cocktail reduces the risk of contracting the virus by 81.6% in the 2 to...
A study published in the journal Lancet states that a common diabetes drug may be an option for treating chronic kidney disease (CKD) in adults. NICE...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches